The Grant for Oncology Innovation (GOI) is an initiative funded by EMD Serono.
Investigators leading innovative research projects that have the potential to advance the implementation of personalised treatment for solid tumours are invited to apply. Potential research topics which could be funded through the Grant for Oncology Innovation include: Research on molecular biomarkers or new targeted treatments, technology platforms for the routine analysis of molecular biomarkers, side effect management and platforms or tools which allow patients to access individualised treatment.
A total grant of up to € 1,000,000 will be awarded to one or more selected projects. The grant will build on the success of the Grant for Fertility Innovation (GFI) and the Grant for Multiple Sclerosis Innovation (GMSI) which between them have awarded grants totalling over 10 million Euros to translational research projects since 2010.
Applications will be evaluated by a Scientific Steering Committee including internationally renowned oncologists and researchers.
The first grants will be awarded to coincide with the European Society for Medical Oncology (ESMO) meeting, 26-30 September, 2014.
Applications for the 2014 GOI award are closed. The awardees will be announced during the ESMO Congress, 26-30 September, Madrid, Spain.
Should you wish to apply for the 2015 grant, applications will re-open from 1 October 2014.